Keheala

Company Overview

Snapshot

Founded in January 2014 by Jon Rathauser, Keheala operates with 1–10 employees. The company has raised a total of $970K across six funding rounds. In September 2017, Keheala was awarded a grant from the United States Agency for International Development to scale its tuberculosis intervention in Kenya.

Business overview

Keheala is a mobile health company focused on improving healthcare access and treatment outcomes by empowering patients with information, motivation, and support. The company delivers tools to address non-medical drivers of disease, while providing healthcare agencies with remote-monitoring capabilities and vital analytics to combat epidemics in resource-constrained environments. Keheala operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Engagement, utilizing AI, Machine Learning, and mobile/web platforms.

Strategic signal

In September 2019, Keheala's innovative work in combating tuberculosis through behavioral science and texting was recognized by the elite medical community, including articles in The New York Times and NoCamels. This highlights the company's success in leveraging simple, scalable technology to address critical global health challenges and improve patient adherence, demonstrating the potential for behavioral interventions in public health.

Company Intelligence Q&A

What is Keheala's primary focus?

Keheala is a mobile health company dedicated to improving healthcare access and treatment outcomes by empowering patients with information, motivation, and support, and providing healthcare agencies with remote-monitoring capabilities.

When was Keheala founded?

Keheala was founded in January 2014.

What significant grant did Keheala receive in 2017?

In September 2017, Keheala was awarded a grant from the United States Agency for International Development to scale its tuberculosis intervention in Kenya.

What was a key recognition for Keheala in September 2019?

In September 2019, Keheala's work in using behavioral science and texting to combat tuberculosis was recognized by the elite medical community, with coverage in The New York Times and NoCamels.